What is the pathophysiology of a molar pregnancy?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 9, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Pathophysiology of Molar Pregnancy

Molar pregnancy results from abnormal fertilization events that produce aberrant chromosomal compositions, leading to trophoblastic proliferation without normal embryonic development.

Complete Hydatidiform Mole (CHM)

Complete moles are diploid and entirely androgenic in origin, containing no maternal genetic material or fetal tissue 1, 2. The pathophysiology follows two distinct mechanisms:

  • Monospermic fertilization (75-80% of cases): A single sperm fertilizes an "empty" ovum (lacking maternal chromosomes), followed by duplication of the paternal haploid genome to create a 46,XX diploid conceptus 1
  • Dispermic fertilization (20-25% of cases): Two sperm fertilize an empty ovum, resulting in 46,XX or 46,XY diploid chromosomes, all of paternal origin 1

The absence of maternal genetic material is critical—all chromosomal material derives from the male, which explains why no fetal parts develop 3. This complete paternal origin drives excessive trophoblastic proliferation without the normal maternal genomic imprinting that would regulate placental growth.

Partial Hydatidiform Mole (PHM)

Partial moles are typically triploid (69 chromosomes), containing two sets of paternal chromosomes and one set of maternal chromosomes 1, 2. The mechanism is:

  • Dispermic fertilization (90% of cases): Two sperm fertilize a normal ovum, creating a triploid conceptus (usually 69,XXY) 1, 2
  • Unlike complete moles, partial moles contain maternal genetic material and evidence of fetal tissue or fetal red blood cells, though the fetus is abnormal and ultimately dies 3

Not all triploid pregnancies are partial moles—the diagnosis requires histopathological evidence of trophoblast hyperplasia 1.

Developmental Progression

The ultrasound evolution of CHM reveals the temporal pathophysiology 4:

  • 4 weeks gestation: Appears as a macroscopically normal gestational sac
  • 5-7 weeks: Transforms into a heterogeneous hyperechogenic polypoid mass (74.4% of cases) or remains as a regular 4-week sac (25.6%)
  • 8+ weeks: Progressive hydropic changes develop, creating the classic vesicular/cystic pattern visible on ultrasound

Cystic molar changes rarely appear before 8 weeks gestation, which explains why early first-trimester diagnosis is challenging 4.

Recurrent Molar Pregnancy

Recurrent cases (affecting 1-2% of subsequent pregnancies) are associated with abnormal genomic imprinting of maternal effect genes 2, 5:

  • NLRP7 (chromosome 19q13.4)
  • KHDC3L (chromosome 6q1)

These mutations disrupt normal maternal genomic imprinting, predisposing to repeated abnormal fertilization events.

Molecular Markers

The p57 (CDKN1C) marker distinguishes complete from partial moles 2:

  • CHM: Loss of p57 nuclear expression in villous cytotrophoblast and stromal cells (reflects absence of maternal genome)
  • PHM: Intact p57 expression (maternal genome present)

This molecular difference reflects the fundamental pathophysiologic distinction between these entities and aids in diagnostic accuracy, particularly in early gestation when histologic features may be subtle 6.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.